N. Kauhanka

Determination of the Risk of Tumor Progression in Patients with Early Stages of Adenocarcinoma and Squamous Cell Lung Carcinoma Based on Laboratory Parameters

A. Tahanovich, N. Kauhanka, V. I. Prohorova, 2022, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry.

New liquid crystalline 3-methyl-6-(4-substituted phenyl)-4,5-dihydrobenzo [d] isoxazoles and 3,5-disubstituted 4,5-dihydroisoxazoles: synthesis and mesomorphic properties

V. Bezborodov, N. Kauhanka, C. J. Lee, 2003 .

New Liquid Crystalline 3,5-disubstituted 4,5-dihydro-1,2-oxazoles

V. Bezborodov, N. Kauhanka, V. Lapanik, 2004 .

Rationale importance of integrated determination of the level of CYFRA 21-1 and the receptors CXCR1, CXCR2, CD44v6 in the blood of patients with early-stage non-small cell lung cancer for predicting the tumor progression risk

A. Tahanovich, N. Kauhanka, V. I. Prohorova, 2022, Proceedings of the National Academy of Sciences of Belarus, Medical series.

Preoperative blood markers for prediction of recurrence-free survival after surgical treatment of patients with stage III lung adenocarcinoma.

A. Tahanovich, N. Kauhanka, D. I. Murashka, 2022, Klinicheskaia laboratornaia diagnostika.

Diagnostic models of non-small cell lung cancer based on determination of blood cytokines and their receptors

A. Tahanovich, N. Kauhanka, V. Prokhorova, 2021, Proceedings of the National Academy of Sciences of Belarus, Medical series.

Significance of the cytokeratin-19 fragment and CXCR1, CXCR2 receptors in the blood for prediction of the relapse-free survival of patients with stage III non-small cell lung cancer

A. Tahanovich, N. Kauhanka, V. Prokhorova, 2023, Proceedings of the National Academy of Sciences of Belarus, Medical series.